Collegium Pharmaceutical Inc (COLL) Stock Analysis

Collegium Pharmaceutical Inc (COLL) is a publicly traded company in the HEALTHCARE sector. It trades at $30.48, carries a market capitalization of $1.03B, a price-to-earnings ratio of 15.43. This page summarizes the public market data, fundamentals, and frequently asked questions for COLL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Collegium Pharmaceutical Inc currently has a Bullish sentiment score of 0.22.

About Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc. is a specialized pharmaceutical company based in Stoughton, Massachusetts, dedicated to the development and commercialization of innovative pain management solutions. The company boasts a diverse portfolio of unique drug formulations that target various pain-related conditions, showcasing its commitment to meeting the complex needs of patients. With a strong focus on enhancing the quality of care in pain management, Collegium is strategically positioned to lead ...

GNG Research Analysis

GNG Research scores Collegium Pharmaceutical Inc (COLL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for COLL.

Frequently Asked Questions

Does COLL pay dividends?

Collegium Pharmaceutical Inc (COLL) does not currently pay a regular dividend.

What is COLL's P/E ratio?

Collegium Pharmaceutical Inc has a price-to-earnings (P/E) ratio of 15.43.

What is COLL's market cap?

Collegium Pharmaceutical Inc (COLL) has a market capitalization of $1.03B with a current stock price of $30.48.